Tommie C Simon1, Matlock A Jeffries2,3. 1. Division of Rheumatology, Immunology, and Allergy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. 2. Division of Rheumatology, Immunology, and Allergy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. matlock-jeffries@ouhsc.edu. 3. Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology Program, 825 NE 13th St., Laboratory MC400, Oklahoma City, OK, USA. matlock-jeffries@ouhsc.edu.
Abstract
PURPOSE OF REVIEW: Epigenomics has emerged as a key player in our rapidly evolving understanding of osteoarthritis. Historical studies implicated epigenetic alterations, particularly DNA methylation, in OA pathogenesis; however, recent technological advances have resulted in numerous epigenome-wide studies examining in detail epigenetic modifications in OA. The purpose of this article is to introduce basic concepts in epigenetics and their recent applications to the study of osteoarthritis development and progression. RECENT FINDINGS: Epigenetics describes three major phenomena: DNA modification via methylation, histone sidechain modifications, and short noncoding RNA sequences which work in concert to regulate gene transcription in a heritable fashion. Cartilage has been the most widely studied tissue in OA, and differential methylation of genes involved in inflammation, cell cycle, TGFβ, and HOX genes have been confirmed several times. Bone studies suggest similar findings, and the intriguing possibility of epigenetic changes in subchondral bone during many OA processes. Multiple studies have demonstrated the involvement of certain noncoding RNAs, particularly miR-140, in OA development via modulation of key catabolic factors. Although much work has been done, much is still unknown. Future epigenomic studies will no doubt continue to widen our understanding of extraarticular tissues and OA pathogenesis, and studies in animal models may offer glimpses into epigenome alterations in the earliest stages of OA.
PURPOSE OF REVIEW: Epigenomics has emerged as a key player in our rapidly evolving understanding of osteoarthritis. Historical studies implicated epigenetic alterations, particularly DNA methylation, in OA pathogenesis; however, recent technological advances have resulted in numerous epigenome-wide studies examining in detail epigenetic modifications in OA. The purpose of this article is to introduce basic concepts in epigenetics and their recent applications to the study of osteoarthritis development and progression. RECENT FINDINGS: Epigenetics describes three major phenomena: DNA modification via methylation, histone sidechain modifications, and short noncoding RNA sequences which work in concert to regulate gene transcription in a heritable fashion. Cartilage has been the most widely studied tissue in OA, and differential methylation of genes involved in inflammation, cell cycle, TGFβ, and HOX genes have been confirmed several times. Bone studies suggest similar findings, and the intriguing possibility of epigenetic changes in subchondral bone during many OA processes. Multiple studies have demonstrated the involvement of certain noncoding RNAs, particularly miR-140, in OA development via modulation of key catabolic factors. Although much work has been done, much is still unknown. Future epigenomic studies will no doubt continue to widen our understanding of extraarticular tissues and OA pathogenesis, and studies in animal models may offer glimpses into epigenome alterations in the earliest stages of OA.
Entities:
Keywords:
DNA methylation; Epigenetics; Osteoarthritis; Review
Authors: María C de Andrés; Kei Imagawa; Ko Hashimoto; Antonio Gonzalez; Helmtrud I Roach; Mary B Goldring; Richard O C Oreffo Journal: Arthritis Rheum Date: 2013-03
Authors: Nils Bomer; Frederique M F Cornelis; Yolande F M Ramos; Wouter den Hollander; Lies Storms; Ruud van der Breggen; Nico Lakenberg; P Eline Slagboom; Ingrid Meulenbelt; Rik J L Lories Journal: Ann Rheum Dis Date: 2014-12-30 Impact factor: 19.103
Authors: Hanna Oppenheimer; Ashok Kumar; Hadar Meir; Israel Schwartz; Avi Zini; Amir Haze; Leonid Kandel; Yoav Mattan; Meir Liebergall; Mona Dvir-Ginzberg Journal: J Bone Miner Res Date: 2014-02 Impact factor: 6.741
Authors: Y Nasu; K Nishida; S Miyazawa; T Komiyama; Y Kadota; N Abe; A Yoshida; S Hirohata; A Ohtsuka; T Ozaki Journal: Osteoarthritis Cartilage Date: 2008-01-15 Impact factor: 6.576
Authors: Nils Bomer; Wouter den Hollander; Yolande F M Ramos; Steffan D Bos; Ruud van der Breggen; Nico Lakenberg; Barry A Pepers; Annelies E van Eeden; Arash Darvishan; Elmar W Tobi; Bouke J Duijnisveld; Erik B van den Akker; Bastiaan T Heijmans; Willeke Mc van Roon-Mom; Fons J Verbeek; Gerjo J V M van Osch; Rob G H H Nelissen; P Eline Slagboom; Ingrid Meulenbelt Journal: Ann Rheum Dis Date: 2014-04-02 Impact factor: 19.103
Authors: Alvaro Del Real; Leyre Riancho-Zarrabeitia; Laura López-Delgado; José A Riancho Journal: Curr Osteoporos Rep Date: 2018-06 Impact factor: 5.096
Authors: Sarah J Rice; Maria Tselepi; Antony K Sorial; Guillaume Aubourg; Colin Shepherd; David Almarza; Andrew J Skelton; Ioanna Pangou; David Deehan; Louise N Reynard; John Loughlin Journal: Arthritis Rheumatol Date: 2019-06-27 Impact factor: 10.995
Authors: Alekya S Tanikella; Makenna J Hardy; Stephanie M Frahs; Aidan G Cormier; Kalin D Gibbons; Clare K Fitzpatrick; Julia Thom Oxford Journal: Int J Mol Sci Date: 2020-08-22 Impact factor: 5.923